New drugs aim to slow muscle decline in duchenne muscular dystrophy
Disease control
Not yet recruiting
This study tests two experimental drugs, ENTR-601-44 and ENTR-601-45, in people with Duchenne muscular dystrophy (DMD) who have already taken part in earlier studies. The goal is to see if long-term use is safe and tolerable, and whether it can help maintain muscle function. Part…
Phase: PHASE2 • Sponsor: Entrada Therapeutics, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC